CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Biopolitical Times

Gene therapy has been the next big thing in medicine for decades. Until recent years, the results were underwhelming. Now there are promising developments and real successes, but significant questions remain: Is it safe enough? How many people might benefit, and under what conditions?  And, crucially, how much will gene therapies cost and who will pay?

It has been more than 50 years since gene therapy was formally proposed; more than 40 years since the first scandal; more than 30...

Biopolitical Times

Cropped from: “Decentralized_Transhumanism” by
Leonel Sohns, CC BY-SA 4.0, via Wikimedia Commons

The techno-utopian credos known as “effective altruism” and “longtermism” have recently gained wide notice, judging by Google searches, news articles, and personal experience. Far less attention has been paid to “hipster eugenics,” a term that brutally but accurately sums up the alarming trend previously known by the perhaps more anodyne “designer babies.” All are closely related.

Effective altruism has been defined rather politely as “a global philanthropic...

Biopolitical Times

The UK Royal Society has published an overview and schedule for the Third International Summit on Human Genome Editing, which...

Aggregated News

One day in 2006, Dorothy Roberts went in for a conference with her youngest son’s teacher. The boy, said the...

Biopolitical Times

Matthew Cobb, As Gods: A Moral History of the Genetic Age, US edition, Basic Books, 2022; aka The Genetic...

Gene therapy has been the next big thing in medicine for decades. Until recent years, the results were underwhelming. Now...

Photo by Isabela Kronemberger on Unsplash

Throughout 2022, CGS worked to deepen and expand collaborations with advocates and scholars concerned...

News

The multimillion-dollar costs of gene therapies -- the type that the state of California is helping to finance -- received some national, mainstream attention during the last few weeks. 

A story in the New York Times on Jan. 24...

The scientist at the heart of the scandal involving the world’s first gene-edited babies has said he moved “too quickly” by pressing ahead with the procedure.

He Jiankui sent shock waves across the world of science when he announced in...

Medical innovations typically take 17 years from the time a lightbulb goes off in a scientist's head until the first person benefits.

But every once in a while, an idea is so powerful and so profound its effects are felt...

It’s easy to think of eugenics as something that happened far away from us, with ideals alien to our character. Yet Adolf Hitler himself studied—and was inspired by—American laws that prevented the birth of people “injurious to the...

Video

A Dangerous Idea: Eugenics in America
Use Gene Editing to Treat Patients, Not Design Babies
CRISPR: What is the future of gene editing? | Start Here